Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7.25M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
4.47M
-
Shares change
-
+146K
-
Total reported value, excl. options
-
$20.5M
-
Value change
-
+$640K
-
Number of buys
-
12
-
Number of sells
-
-12
-
Price
-
$4.58
Significant Holders of Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) as of Q2 2025
43 filings reported holding KZR - Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share as of Q2 2025.
Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.47M shares
of 7.25M outstanding shares and own 61.68% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (720K shares), SUVRETTA CAPITAL MANAGEMENT, LLC (717K shares), BML Capital Management, LLC (635K shares), Avidity Partners Management LP (503K shares), VANGUARD GROUP INC (276K shares), ORBIMED ADVISORS LLC (193K shares), Stonepine Capital Management, LLC (170K shares), ADAR1 Capital Management, LLC (147K shares), ACADIAN ASSET MANAGEMENT LLC (134K shares), and Peapod Lane Capital LLC (115K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.